SCHEMBL5221774

SCHEMBL5221774

CCNc1cc(C(=O)OC)c(F)c(N2CCCS2(=O)=O)c1

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 10/20 0.49
BACE2 Q9Y5Z0 9/20 0.49
CTSD P07339 8/20 0.49
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
TP53 P04637 6/20 0.38
PIK3C3 Q8NEB9 2/20 0.36
MAPT P10636 1/20 0.36
GAA P10253 1/20 0.34
ALOX15 P16050 1/20 0.34
MAPK1 P28482 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5219943 0.97 BACE1 (0.53) BACE1BACE2CTSDCYP3A4CYP2D6
SCHEMBL5221778 0.89 BACE1 (0.41) BACE1BACE2CTSDCYP3A4CYP2D6
SCHEMBL5223174 0.89 BACE1 (0.49) BACE1BACE2CTSDCYP3A4CYP2D6
SCHEMBL5219939 0.86 BACE1 (0.43) BACE1BACE2CTSDCYP3A4CYP2D6
SCHEMBL5220634 0.85 BACE1 (0.52) BACE1BACE2CTSDCYP3A4CYP2D6
SCHEMBL5221011 0.84 CTSD (0.39) BACE1BACE2CTSDCYP3A4CYP2D6
SCHEMBL5219076 0.83 BACE1 (0.47) BACE1BACE2CTSDCYP3A4CYP2D6
SCHEMBL5221784 0.82 CTSD (0.42) BACE1BACE2CTSDCYP3A4CYP2D6
SCHEMBL5223775 0.81 KDM4E (0.39) BACE1BACE2CTSDCYP3A4CYP2D6
SCHEMBL5226784 0.81 PIK3C3 (0.39) BACE1BACE2CTSDTP53PIK3C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed